首页> 美国卫生研究院文献>Journal of Drug Delivery >Etodolac Containing Topical Niosomal Gel: Formulation Development and Evaluation
【2h】

Etodolac Containing Topical Niosomal Gel: Formulation Development and Evaluation

机译:含依托多拉克的局部Niosomal凝胶:配方开发和评估。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study aimed to investigate the delivery potential of Etodolac (ETD) containing topical niosomal gel. Niosomal formulations were prepared by thin film hydration method at various ratios of cholesterol and Span 60 and were evaluated with respect to particle size, shape, entrapment efficiency, and in vitro characteristics. Dicetyl phosphate (DCP) was also added in the niosomal formulation. Mean particle size of niosomal formulation was found to be in the range of 2 μm to 4 μm. Niosomal formulation N2 (1 : 1) ratio of cholesterol and surfactant displayed good entrapment efficiency (96.72%). TEM analyses showed that niosomal formulation was spherical in shape. Niosomal formulation (N2) displayed high percentage of drug release after 24 h (94.91) at (1 : 1) ratio of cholesterol : surfactant. Further selected niosomal formulation was used to formulate topical gel and was characterized with respect to its various parameters such as pH, viscosity, spreadability, ex vivo study, and in vivo potential permeation. Ex vivo study showed that niosomal gel possessed better skin permeation study than the plain topical gel. Further in vivo study revealed good inhibition of inflammation in case of topical niosomal gel than plain gel and niosomal formulation. The present study suggested that topical niosomal gel formulations provide sustained and prolonged delivery of drug.
机译:本研究旨在调查含有局部性尼古斯丁凝胶的依托度拉克(ETD)的传递潜力。通过薄膜水化法以胆固醇和Span 60的不同比例制备了脂质体制剂,并对其粒径,形状,包封效率和体外特性进行了评估。磷酸二鲸蜡酯(DCP)也被添加到了血浆配方中。测得的染色体制剂的平均粒径在2μm至4μm的范围内。胆固醇和表面活性剂的比例为N2的N2(1:1)比例具有良好的包封率(96.72%)。 TEM分析表明,染色体组为球形。脂质体(N2)在胆固醇:表面活性剂的比例为(1 :: 1)时24 h(94.91)后显示出高百分比的药物释放。进一步选择的纳米脂质体制剂用于配制局部用凝胶,并就其各种参数(例如pH值,粘度,铺展性,离体研究和体内潜在渗透)进行了表征。离体研究表明,与普通的局部用凝胶相比,唾液酸凝胶具有更好的皮肤渗透性研究。进一步的体内研究表明,与单纯的凝胶剂和脂质体制剂相比,局部脂质体凝胶对炎症具有良好的抑制作用。本研究表明局部性的染色体组凝胶制剂可提供持续和延长的药物输送。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号